AnaptysBio, Inc. ANAB EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from AnaptysBio, Inc.’s reported figures.
Based on trailing twelve months.
The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about AnaptysBio, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AnaptysBio, Inc.'s EBITDA margin?
- AnaptysBio, Inc. (ANAB) reported EBITDA margin of 17.8% in Q1 2026.
- How has AnaptysBio, Inc.'s EBITDA margin changed year-over-year?
- AnaptysBio, Inc.'s EBITDA margin increased by 120.0% year-over-year, from -89.1% to 17.8%.
- What is the long-term trend for AnaptysBio, Inc.'s EBITDA margin?
- Over 4 years (2021 to 2025), AnaptysBio, Inc.'s EBITDA margin has grown at a -30.6% compound annual growth rate (CAGR), from -89% to 20.7%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.